中红医疗
(300981)
| 流通市值：14.13亿 | | | 总市值：44.85亿 |
| 流通股本：1.23亿 | | | 总股本：3.90亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,395,609,123.31 | 776,195,507.2 | 614,211,038.94 | 596,551,248.09 |
| 结算备付金 | 0 | 0 | - | - |
| 拆出资金 | 0 | 0 | - | - |
| 衍生金融资产 | 0 | 0 | - | - |
| 应收票据及应收账款 | 429,594,687.83 | 355,488,985.25 | 421,897,839.48 | 400,065,761.35 |
| 其中：应收票据 | 7,343,335.67 | 10,452,566.22 | 10,071,449.49 | 10,039,446.86 |
| 应收账款 | 422,251,352.16 | 345,036,419.03 | 411,826,389.99 | 390,026,314.49 |
| 应收款项融资 | 3,247,129.08 | 4,370,460.16 | 2,635,776.21 | 4,981,139.97 |
| 预付款项 | 59,461,534.98 | 25,850,416.56 | 42,487,263.12 | 40,921,723.85 |
| 应收保费 | 0 | 0 | - | - |
| 应收分保账款 | 0 | 0 | - | - |
| 应收分保合同准备金 | 0 | 0 | - | - |
| 其他应收款合计 | 30,058,691.57 | 36,271,352.3 | 29,762,632.9 | 36,974,225.71 |
| 其中:应收利息 | 0 | 0 | - | - |
| 应收股利 | 0 | 0 | - | - |
| 买入返售金融资产 | 0 | 0 | - | - |
| 存货 | 547,355,266.9 | 504,876,281.32 | 487,035,132.89 | 559,679,596.23 |
| 一年内到期的非流动资产 | 254,602,690.68 | 101,292,896.17 | - | - |
| 其他流动资产 | 553,791,181.28 | 654,542,120.67 | 565,969,810.1 | 844,085,605.52 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,709,692,660.21 | 3,997,261,836.1 | 4,222,859,023.56 | 4,341,982,673.58 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | - | - |
| 债权投资 | 14,522,655.33 | 14,314,039.67 | 120,124,016.34 | 119,171,813.86 |
| 其他债权投资 | 0 | 0 | - | - |
| 长期应收款 | 0 | 0 | - | - |
| 长期股权投资 | 5,831,391.36 | 5,831,391.36 | 5,557,302.45 | 5,631,618.75 |
| 其他权益工具投资 | 96,223,195.05 | 93,834,283.49 | 97,641,353.41 | 96,741,116.36 |
| 其他非流动金融资产 | 103,167,709 | 364,310,448.73 | 84,651,732.91 | 84,651,732.91 |
| 投资性房地产 | 0 | 0 | - | - |
| 固定资产 | 1,887,593,749.21 | 1,927,244,211.15 | 1,856,140,193.26 | 1,891,609,338.61 |
| 在建工程 | 109,853,958.07 | 106,957,904.52 | 88,866,278.46 | 83,572,482.22 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 11,168,609.29 | 12,875,559.8 | 12,601,132.47 | 14,820,860.17 |
| 无形资产 | 167,760,247.51 | 170,360,807.44 | 184,748,509.02 | 182,494,350.71 |
| 开发支出 | 0 | 0 | - | - |
| 商誉 | 295,293,771.52 | 295,293,771.52 | 354,953,646.08 | 354,953,646.08 |
| 长期待摊费用 | 3,762,861.42 | 2,847,991.08 | 4,744,884.84 | 1,844,516.26 |
| 递延所得税资产 | 55,996,916.7 | 58,532,676.03 | 62,331,754.88 | 61,052,299.47 |
| 其他非流动资产 | 103,392,787.53 | 7,309,069.16 | 151,681,385.09 | 139,694,028.99 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,854,567,851.99 | 3,059,712,153.95 | 3,024,042,189.21 | 3,036,237,804.39 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 7,564,260,512.2 | 7,056,973,990.05 | 7,246,901,212.77 | 7,378,220,477.97 |
| 流动负债: | | | | |
| 短期借款 | 494,646,798.58 | 153,544,691.05 | 160,641,099.95 | 227,828,476.69 |
| 向中央银行借款 | 0 | 0 | - | - |
| 吸收存款及同业存放 | 0 | 0 | - | - |
| 拆入资金 | 0 | 0 | - | - |
| 交易性金融负债 | 16,584,700 | 23,147,196.08 | 13,600,470 | 13,719,717.09 |
| 衍生金融负债 | 0 | 0 | - | - |
| 应付票据及应付账款 | 497,016,607.18 | 411,400,458.03 | 427,389,102.63 | 490,205,569.17 |
| 其中：应付票据 | 151,618,660.33 | 149,870,869.06 | 182,823,963.71 | 170,295,533.24 |
| 应付账款 | 345,397,946.85 | 261,529,588.97 | 244,565,138.92 | 319,910,035.93 |
| 预收款项 | 0 | 0 | 0 | - |
| 合同负债 | 80,174,097.18 | 59,706,335.43 | 70,181,437.45 | 67,698,784.06 |
| 卖出回购金融资产款 | 0 | 0 | - | - |
| 应付手续费及佣金 | 0 | 0 | - | - |
| 应付职工薪酬 | 60,337,276.46 | 59,897,643.23 | 49,035,109.91 | 52,374,732.45 |
| 应交税费 | 9,088,498.09 | 15,213,995.88 | 5,730,684.61 | 5,291,124.31 |
| 其他应付款合计 | 16,638,224.37 | 18,716,136.43 | 25,321,568.68 | 42,370,724.72 |
| 其中:应付利息 | 0 | 0 | 0 | - |
| 应付股利 | 0 | 0 | - | - |
| 应付分保账款 | 0 | 0 | - | - |
| 保险合同准备金 | 0 | 0 | - | - |
| 代理买卖证券款 | 0 | 0 | - | - |
| 代理承销证券款 | 0 | 0 | - | - |
| 一年内到期的非流动负债 | 318,460,556.15 | 16,716,114.49 | 21,112,943.59 | 19,809,857.22 |
| 其他流动负债 | 9,025,875.22 | 11,817,747.09 | 11,565,229.52 | 11,829,131.6 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,501,972,633.23 | 770,160,317.71 | 784,577,646.34 | 931,128,117.31 |
| 非流动负债: | | | | |
| 长期借款 | 107,529,200 | 331,300,000 | 358,990,000 | 358,790,000 |
| 应付债券 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 6,938,675.04 | 7,284,183.54 | 7,974,073.16 | 8,987,056.38 |
| 长期应付款 | 1,225,471.69 | 1,225,471.69 | 612,735.85 | 1,225,471.69 |
| 长期应付职工薪酬 | 0 | 0 | 0 | - |
| 预计负债 | 0 | 0 | - | - |
| 递延收益 | 22,361,162.68 | 17,577,525.07 | 34,866,183.08 | 35,027,111.11 |
| 递延所得税负债 | 13,627,543.09 | 14,405,149.74 | 14,329,872.15 | 14,036,351.7 |
| 其他非流动负债 | 0 | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 151,682,052.5 | 371,792,330.04 | 416,772,864.24 | 418,065,990.88 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,653,654,685.73 | 1,141,952,647.75 | 1,201,350,510.58 | 1,349,194,108.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 390,007,800 | 390,007,800 | 390,007,800 | 390,007,800 |
| 其他权益工具 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 资本公积 | 1,715,857,615.94 | 1,715,843,746.94 | 1,715,843,746.94 | 1,715,843,746.94 |
| 减:库存股 | 15,890,528.17 | 8,957,457.27 | - | - |
| 其他综合收益 | 8,875,008.5 | 7,431,870.06 | 11,682,309.98 | 11,008,558.34 |
| 专项储备 | 0 | 0 | - | - |
| 盈余公积 | 95,661,783.43 | 95,661,783.43 | 95,661,783.43 | 95,661,783.43 |
| 一般风险准备 | 0 | 0 | - | - |
| 未分配利润 | 3,569,385,641.8 | 3,568,098,446.96 | 3,708,166,222.14 | 3,694,026,430.18 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,763,897,321.5 | 5,768,086,190.12 | 5,921,361,862.49 | 5,906,548,318.89 |
| 少数股东权益 | 146,708,504.97 | 146,935,152.18 | 124,188,839.7 | 122,478,050.89 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,910,605,826.47 | 5,915,021,342.3 | 6,045,550,702.19 | 6,029,026,369.78 |
| 负债和股东权益合计 | 7,564,260,512.2 | 7,056,973,990.05 | 7,246,901,212.77 | 7,378,220,477.97 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-25 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |